Literature DB >> 11224094

Modulation of the discriminative-stimulus effects of cocaine by buprenorphine.

J.B. Kamien1, R.D. Spealman.   

Abstract

Modulation of the discriminative-stimulus effects of cocaine by the mixed-action opioid buprenorsphine was studied in squirrel monkeys trained to discriminate cocaine from saline, using a two-lever drug discrimination procedure. Lever pressing was maintained under a fixed-ratio 10 schedule of food presentation. During test sessions, monkeys received cumulative doses of cocaine after presession treatment with either saline or buprenorphine (0.001-0.01mg/kg). After pretreatment with saline, cocaine engendered dose-related increases in the percentage of cocaine-appropriate responses, reaching a maximum of 99-100 percent at doses of 0.3 or 1.0mg/kg. Pretreatment with buprenorphine shifted the cocaine dose-response function to the left, resulting in 98-100 percent cocaine-appropriate responding at doses of cocaine that previously engendered only saline-appropriate responding. When tested alone, buprenorphine did not occasion cocaine-appropriate responding at any dose. The results show that although buprenorphine does not itself have cocaine-like discriminative-stimulus effects, it can potentiate the discriminative-stimulus effects of cocaine.

Entities:  

Year:  1991        PMID: 11224094

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  2 in total

1.  Discriminative stimulus effects of the 5HT1A agonist 8-OH-DPAT: attenuation by mu but not by kappa opioids.

Authors:  D Morgan; M J Picker
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.

Authors:  Walter Ling; Maureen P Hillhouse; Andrew J Saxon; Larissa J Mooney; Christie M Thomas; Alfonso Ang; Abigail G Matthews; Albert Hasson; Jeffrey Annon; Steve Sparenborg; David S Liu; Jennifer McCormack; Sarah Church; William Swafford; Karen Drexler; Carolyn Schuman; Stephen Ross; Katharina Wiest; P Todd Korthuis; William Lawson; Gregory S Brigham; Patricia C Knox; Michael Dawes; John Rotrosen
Journal:  Addiction       Date:  2016-04-21       Impact factor: 6.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.